GENNEXPharmaceuticals
Gennex Laboratories Ltd — PE Ratio & Valuation Analysis
₹7.13
-11.88%
Current P/E20.66xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E22.5x8.4% below avg
✅
35.0% Discount to Industry
GENNEX P/E 20.66x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹0.78 | ₹14 | 18.2x |
| 2024 | ₹0.61 | ₹16 | 26.9x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Gennex Laboratories Ltd Valuation
Gennex Laboratories Ltd (GENNEX) currently trades at 20.66x earnings. The Pharmaceuticals sector average PE is 31.77x. GENNEX is trading at a discount to peers — may indicate relative value. Historically, GENNEX has traded at an average PE of 22.5x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
10.23%
Dividend Yield
0.00%
More on Gennex Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.